Učitavanje...
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
BACKGROUND: One of the major challenges in diagnosing dementia with Lewy bodies (DLB) is the common co-morbid presence of amyloid pathology. To understand the putative role of altered amyloid-β (Aβ) metabolism in dementia with DLB, we analyzed levels of different cerebrospinal fluid (CSF) Aβ peptide...
Spremljeno u:
| Izdano u: | Alzheimers Res Ther |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6788069/ https://ncbi.nlm.nih.gov/pubmed/31601267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-019-0537-5 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|